For payers, the expectation should be that international reference pricing will eventually become embedded in the American system
Most notably, the FLOW trial, the first dedicated GLP-1 RA kidney outcome trial, demonstrated that once-weekly semaglutide reduced the risk of sustained decline in estimated glomerular filtration rate (eGFR), kidney failure or cardiovascular death in people with CKD and T2D [9]
Not just absorption speed, but tissue distribution, half-life extension, and whether the peptide reaches dermal fibroblasts at concentrations high enough to activate matrix metalloproteinase regulation
Remember that it is one of the most powerful antioxidants in the body as it is the only one that is intracellular, so regular nutrient IV treatments is an easy way to check it off your list.
Additionally, free radicals can directly damage endothelial cells, further compromising their ability to regulate vascular tone [78]